BofA analyst Joshua Dennerlein downgraded Sabra Health Care to Underperform from Neutral with a $33 price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SBRA:
Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
The Fly
Sabra Health Care downgraded to Underperform from Neutral at BofA
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
